Returning personal genetic information on susceptibility to arsenic toxicity to research participants in Bangladesh.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 Jan 2024
Historique:
received: 31 07 2023
revised: 13 10 2023
accepted: 22 10 2023
medline: 21 11 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

There is growing consensus that researchers should offer to return genetic results to participants, but returning results in lower-resource countries has received little attention. In this study, we return results on genetic susceptibility to arsenic toxicity to participants in a Bangladeshi cohort exposed to arsenic through naturally-contaminated drinking water. We examine the impact on behavioral changes related to exposure reduction. We enrolled participants from the Health Effects of Arsenic Longitudinal Study who had (1) high arsenic (≥150 μg/g creatinine) in a recent urine sample and (2) existing data on genetic variants impacting arsenic metabolism efficiency (AS3MT and FTCD). We used genetic data to recruit three study groups, each with n = 103: (1) efficient metabolizers (low-risk), (2) inefficient metabolizers (high-risk), and (3) a randomly-selected control group (NCT05072132). At baseline, all participants received information on the effects of arsenic and how to reduce exposure by switching to a low arsenic well. The two intervention groups also received their arsenic metabolism efficiency status (based on their genetic results). Changes in behavior and arsenic exposure were assessed using questionnaires and urine arsenic measures after six months. Clear decreases in urine arsenic after six months were observed for all three groups. The inefficient group self-reported higher levels of attempted switching to lower arsenic wells than the other groups; however, there was no detectable difference in urine arsenic reduction among the three groups. Participants showed strong interest in receiving genetic results and found them useful. The inefficient group experienced higher levels of anxiety than the other groups. Among the efficient group, that receiving genetic results did not appear to hinder behavioral change. Returning genetic results increased self-reported exposure-reducing behaviors but did not have a detectable impact on reducing urine arsenic over and above a one-on-one educational intervention.

Sections du résumé

BACKGROUND BACKGROUND
There is growing consensus that researchers should offer to return genetic results to participants, but returning results in lower-resource countries has received little attention. In this study, we return results on genetic susceptibility to arsenic toxicity to participants in a Bangladeshi cohort exposed to arsenic through naturally-contaminated drinking water. We examine the impact on behavioral changes related to exposure reduction.
METHODS METHODS
We enrolled participants from the Health Effects of Arsenic Longitudinal Study who had (1) high arsenic (≥150 μg/g creatinine) in a recent urine sample and (2) existing data on genetic variants impacting arsenic metabolism efficiency (AS3MT and FTCD). We used genetic data to recruit three study groups, each with n = 103: (1) efficient metabolizers (low-risk), (2) inefficient metabolizers (high-risk), and (3) a randomly-selected control group (NCT05072132). At baseline, all participants received information on the effects of arsenic and how to reduce exposure by switching to a low arsenic well. The two intervention groups also received their arsenic metabolism efficiency status (based on their genetic results). Changes in behavior and arsenic exposure were assessed using questionnaires and urine arsenic measures after six months.
RESULTS RESULTS
Clear decreases in urine arsenic after six months were observed for all three groups. The inefficient group self-reported higher levels of attempted switching to lower arsenic wells than the other groups; however, there was no detectable difference in urine arsenic reduction among the three groups. Participants showed strong interest in receiving genetic results and found them useful. The inefficient group experienced higher levels of anxiety than the other groups. Among the efficient group, that receiving genetic results did not appear to hinder behavioral change.
CONCLUSION CONCLUSIONS
Returning genetic results increased self-reported exposure-reducing behaviors but did not have a detectable impact on reducing urine arsenic over and above a one-on-one educational intervention.

Identifiants

pubmed: 37879393
pii: S0013-9351(23)02286-7
doi: 10.1016/j.envres.2023.117482
pii:
doi:

Substances chimiques

Arsenic N712M78A8G
AS3MT protein, human EC 2.1.1.137
Methyltransferases EC 2.1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117482

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lizeth I Tamayo (LI)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA.

Syed Emdadul Haque (SE)

University of Chicago Research Bangladesh, Dhaka, Bangladesh.

Tariqul Islam (T)

University of Chicago Research Bangladesh, Dhaka, Bangladesh.

Alauddin Ahmed (A)

University of Chicago Research Bangladesh, Dhaka, Bangladesh.

Moziber Rahman (M)

University of Chicago Research Bangladesh, Dhaka, Bangladesh.

Abu Horayra (A)

University of Chicago Research Bangladesh, Dhaka, Bangladesh.

Lin Tong (L)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA.

Lin Chen (L)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA.

Aresha Martinez-Cardoso (A)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA.

Habibul Ahsan (H)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA; Department of Human Genetics, University of Chicago, Chicago, IL, 60615, USA; Department of Medicine, University of Chicago, Chicago, IL, 60615, USA.

Brandon L Pierce (BL)

Department of Public Health Sciences, University of Chicago, Chicago, IL, 60615, USA; Department of Human Genetics, University of Chicago, Chicago, IL, 60615, USA; Comprehensive Cancer Center, University of Chicago, Chicago, IL, 60615, USA. Electronic address: brandonpierce@uchicago.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH